[Retracted] Osmotic Demyelination Syndrome: Clinical, Neuroimaging Characteristics, and Outcomes in a Series of 18 Cases

Table 3

Clinical characters of participants.

Patient	Age (y)	Sex	Treatment	MMSE (before)	MMSE (after)	Water swallowing test (before)	Water swallowing test (after)	GCS (before)	GCS (after)	Water swallowing test (after rehab)
1	54	M	Symptomatic treatment	29
2	30	M	Symptomatic treatment	29
3	53	F	Symptomatic treatment	18	29
4	78	F	Symptomatic treatment+dexamethasone 10 mg	Not cooperative	Not cooperative	Not cooperative		6	10
5	30	M	Symptomatic treatment+dexamethasone 10 mg			4	3			2
6	38	F	Symptomatic treatment	20	29	1	1
7	52	M	Symptomatic treatment	17	28	4	2
8	47	F	Symptomatic treatment	20	29	4	3			2
9	34	F	Symptomatic treatment	15	26	4	3
10	61	M	Symptomatic treatment
11	60	M	Symptomatic treatment			3	2
12	26	F	Symptomatic treatment			3	2			1
13	55	M	Symptomatic treatment			4	3			3
14	40	M	Symptomatic treatment	16	27	2	2			2
15	39	M	Symptomatic treatment	20	29
16	58	F	Symptomatic treatment	18	29
17	49	M	Symptomatic treatment	18	28	3	2
18	50	F	Symptomatic treatment	19	29